Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depo-Provera CI Dose-Finding Study
NCT02732418Phase 1Completed
- Sponsor
- FHI 360
- Start
- Dec 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 1, randomised, single-blind trial of medroxyprogesterone acetate in contraception (4 arms), sponsored by FHI 360. Primary endpoint: Time to ovulation at 32 weeks. Started Dec 2016; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02732418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732418.